Serum hepatitis B core-related antigen for the prediction of hepatocellular carcinoma development

[1]  R. Pellicano,et al.  Hepatitis B Core-Related Antigen: A Serum Biomarker for Intrahepatic Covalently-Closed-Circular DNA. , 2018, Clinical laboratory.

[2]  S. Fagoonee,et al.  Liver fibrosis: the 2017 state of art. , 2017, Panminerva medica.

[3]  G. P. Caviglia,et al.  Hepatitis B core-related antigen: a novel biomarker for chronic hepatitis B treatment. , 2017, Minerva Gastroenterologica e Dietologica.

[4]  M. Yuen,et al.  Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy , 2017, Journal of viral hepatitis.

[5]  M. Rizzetto,et al.  Hepatitis B core‐related antigen kinetics in chronic hepatitis B virus genotype D‐infected patients treated with nucleos(t)ide analogues or pegylated‐interferon‐α , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[6]  M. Rizzetto,et al.  Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. , 2017, Panminerva medica.

[7]  H. Toyoda,et al.  HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics. , 2016, Journal of hepatology.

[8]  M. Honda,et al.  Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma. , 2016, The Journal of infectious diseases.

[9]  Kenta Yamamoto,et al.  Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis. , 2013, Journal of hepatology.

[10]  Yoshiyuki Suzuki,et al.  HBcrAg is a predictor of post‐treatment recurrence of hepatocellular carcinoma during antiviral therapy , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[11]  R. Pellicano,et al.  Role of serum hepatitis B core-related antigen in chronic hepatitis B infection , 2018 .